Genome alterations of seven secondary tumors (®ve osteosarcomas, one malignant peripheral sheath nerve tumor, one leiomyosarcoma) occurring in the ®eld of irradiation of patients treated for bilateral retinoblastoma have been studied. These patients were predisposed to develop radiation-induced tumors because of the presence of a germ line mutation in the retinoblastoma gene (RB1). Tumor cells were characterized by a high chromosome instability whereas microsatellites and minisatellites were found to be stable. In all tumors, the normal RB1 allele was lost with the corresponding chromosome 13, whereas the germ line mutated allele was retained. The two alleles of TP53 were inactivated, one by deletion of the short arm of chromosome 17, the other by mutation. As compared with non-radiationinduced tumors, the observed panel of TP53 mutations was uncommon with sites not recurrently found otherwise and a high rate of deletions (3/7). In these predisposed patients, the loss of the single normal allele of RB1 is rather due to the radiation-induced chromosome instability than a direct eect of ionizing radiation. Oncogene (2001) 20, 8092 ± 8099.
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Introduction
Despite extensive epidemiological studies and numerous case reports of ionizing radiation-induced human solid tumors, little data is available on the genetic alterations present in these cancers. In particular, it is not currently known if speci®c pathways of cancerogenesis are involved compared to spontaneous cancers of identical histological origin. Such studies are dicult to carry out because of the heterogeneous origin of these cancers and the diculty in collecting a series of cases in clearly de®ned context.
It is well established that therapeutic irradiation can induce secondary malignancies within or at the margin of the radiation ®eld after a long latent period. These tumors have dierent histology from the primary lesions, with sarcomas being common (Robinson et al., 1988) . Well documented data are available on radiation-induced thyroid tumors developing after radiotherapy or accidental irradiation. A key role of the RET protooncogene was demonstrated in radiation-induced as well as in spontaneous thyroid tumors, but both the frequency and the speci®city of RET rearrangements seemed to be higher in radiationinduced tumors (Bongarzone et al., 1997; Bounacer et al., 1997; Klugbauer et al., 1995; Nikiforov et al., 1997 Nikiforov et al., , 1999 . Data is also available for other cancers developing after radiotherapy. Cytogenetic data indicated that these radiation-induced cancers generally had complex karyotypes with multiple deletions and chromosome losses (Chauveinc et al., 1999; Mertens et al., 2000) . This suggests that complex oncogenic processes are involved. The molecular analysis of two series of radiation-induced tumors of the central nervous system has been published. No signi®cant dierence in the pattern of gene alterations was observed between radiation-induced and spontaneous astrocytomas (Brat et al., 1999) . In contrast, for meningioma, it was concluded that radiation-induced forms displayed a distinct pattern of molecular genetic alterations from that observed in spontaneous tumors (Shoshan et al., 2000) . De®nitive conclusions cannot be drawn about secondary lung and breast cancers developing after radiotherapy for Hodgkin's disease. In a series of lung cancers (De Benedetti et al., 1996) , radiation-induced characteristic mutations of TP53 gene were assumed to be present, whereas this was not con®rmed in more recent work (Behrens et al., 2000) . In the latter study, an increase of microsatellite instability was noticed, as compared with sporadic cases, in therapy-related tumors post-Hodgkin's disease. However, the role of smoking in pulmonary neoplasia and the recurrent combination of chemother-apy and radiotherapy complicates the interpretation of these data.
The paucity of available data does not allow an overview of the speci®c eects of ionizing radiation in the induction of human tumors. In particular, the role and the consequences of genetic predispositions are poorly understood. Data on second cancers occurring after childhood cancers indicate that genetic predispositions may also predispose to radiotherapy-related cancers (de Vathaire et al., 1992) . Patients carrying a germ line mutation of the retinoblastoma gene (RB1) usually develop bilateral retinoblastoma (Draper et al., 1992; Vogel, 1979) . In addition to having a high risk of developing other spontaneous cancers, these patients also have a high frequency of secondary tumors, in particular, osteosarcomas, in the ®eld of irradiation. Cumulative incidence of a secondary cancer at 50 years after diagnosis was 51% for patients with predisposition and 5% for patients which developed nonhereditary retinoblastoma (Wong et al., 1997) .
These radiation-induced cancers, developing in a known genetic context, may provide an opportunity to determine the pathways underlying the radiationinduced eects. We have studied seven secondary tumors developing in the ®eld of irradiation in patients treated for bilateral retinoblastoma. We show that, in these tumors characterized by high chromosome instability, the normal allele of RB1 was lost with deletion of the chromosome 13 (where the RB1 gene is localized) and not by inactivation due to an intragenic mutation attributable to the ionizing radiation. Moreover, the uncommon panel of mutations observed on TP53 suggests the presence of mutational mechanisms which could be speci®c to, or particularly active in, radiation-induced tumors.
Results

Patients
Seven children with bilateral retinoblastoma underwent therapeutic irradiation between 4 ± 14 months of age (Table 1) . Case 2 was a low penetrancy familial case. No retinoblastoma was reported in other families.
Radiotherapy was administered by photon or by electron. The total radiation dose was 45 Gy. After a latent period of 7 ± 22 years, a secondary tumor developed in the radiation ®eld. These tumors (®ve osteosarcomas, one malignant peripheral sheath nerve tumor, one leiomyosarcoma) were considered to be radiation-induced according to the Cahan criteria (Cahan et al., 1948) .
RB1 and TP53 analysis
LOH analyses were performed on the seven radiationinduced tumors (Table 1) , using microsatellite sequences distributed along the whole of chromosomes 13 and 17 where the RB1 and TP53 genes are localized on bands 13q14.1 and 17p13.1, respectively. Twentyone loci were analysed on chromosome 13, including three in the RB1 gene, and 16 on chromosome 17, including one in the TP53 gene (Figure 1 ). For the three intragenic loci of RB1, LOH were observed in all informative microsatellites indicating the loss of one allele in the seven studied cases. For cases 1, 3, 4, 5 and 7, data were in favor of a whole chromosome 13 loss. For case 2, several loci in the distal and proximal parts of the chromosome 13 were not informative and it was not possible to establish the boundaries of the deletion. Heterozygosity was maintained only in the distal part of chromosome 13 for case 6, suggesting that a large deletion occurred. The TP53 intragenic microsatellite indicated a LOH in all of the six informative cases. In case 1, the loss of one copy of TP53 could be expected since TP53 was surrounded by loci which underwent LOH (see also below). For cases 2, 3 and 4, a whole chromosome 17 short arm was deleted. In contrast, for cases 1, 5 and 6, the proximal part of the arm was not lost. All chromosome 17 was lost in case 7, no LOH being observed in the six other cases on the 17q arm. To determine the status of the remaining allele of RB1 and TP53 in the tumors, the coding regions and parts of some introns were analysed by DGGE and/or by sequencing.
With the exception of two cases for which RNA from normal tissue (case 3) or tumor (case 7) was not available, the full length coding sequence of RB1 was ®rst studied by DGGE using RNA from both tumor and normal tissues. In cases 2, 4 and 6, one RT ± PCR fragment prepared for DGGE analysis was found to harbor a deletion. In these tumors, the other DGGE fragments did not display abnormal electrophoretic behavior. The fragments with deletions were sequenced and it was shown that the totality of exon 9 in case 2 and of exon 12 in cases 4 and 6 were missing. Deletion of exon 9 maintained the open reading frame, whereas those of exon 12 induced a stop codon at position 380 (Table 2 ). In case 2, the deletion of exon 8 was associated with a T?C transition in the polypyrimidine tract of the 5' splicing site localized in intron 8. This mutation strongly reduces the splicing eciency of exon 9 (unpublished data). In cases 4 and 6, the 3' splicing site of exon 12 was altered by a G?A transition (ac/GT?ac/AT). Only one abnormal electrophoretic fragment encompassing exons 17 and 23, in cases 1 and 3 respectively, was demonstrated by DGGE. In exon 17, a C?T transition at codon 556 introduced a stop codon. In exon 23, the deletion of a T at codon 777 introduced a stop codon in 809. All these mutations were con®rmed on genomic DNA (Table 2) . For tumor ®ve, deletion of exons 7, 8 and 9 was found by cDNA sequencing and con®rmed by multiprimer analysis of the DNA. For tumor seven, a Leu?Val missense mutation was found at codon 12 by sequencing the whole cDNA. This mutation was not found in the screening of 200 DNA from healthy donors and thus is unlikely to be a polymorphism (not shown). In all the cases, the RB1 constitutionally mutant allele was detected in the normal tissue jointly with the wild type allele, whereas only the mutant allele was detected in the tumors. In cases 1, 2, 3, 4 and 6, the germ line mutation induced the formation of a non-functional protein. The situation in case 7 was less clear since the mutation observed corresponded to a Leu?Val change in the N-terminal region of the protein, a region where few mutations have been described (Lohmann, 1999) and whose function is not well characterized (Kaelin, 1999) . The consequence of the amino-acid change on the functionality of the protein is dicult to estimate, but several arguments suggest that this mutation is actually the germ line mutation and is sucient to signi®cantly alter the activity of the protein: (1) no other mutation was found in the gene; (2) it is not a known polymorphism; (3) the mutation was found to be heterozygous in the normal tissue and the other allele was lost in the tumor. Thus, in these seven tumors, the tumor suppressor role of RB1 was altered.
Somatic mutations of the TP53 gene were analysed by cDNA sequencing in ®ve tumors (cases 1, 3 ± 6) and the found mutations were con®rmed by studying the corresponding genomic DNA. For cases 2 and 7, RNA Analysis performed on tumoral DNA and RNA, the absence of mutation was veri®ed on peripheral lymphocytes. c Deletion found by multiprimer analysis, the extent of the deletion in 3' and 5' of the three exons was not precisely mapped. d Identical results were obtained in fresh and xenografted tumors was missing and mutations were searched for in tumor DNA only (Table 2) . Missense mutations, localized in exon 5, 6 or 7, were found in four cases. The three other mutations were deletions in exon 4 (2 bp), 8 (4 bp) and 5. In the latter, a genomic 134 bp deletion overlapping the 3' splicing site of exon 5 was observed. The removal of this splicing site induced the nonrecognition of the partially deleted intron 5 (16 bp remaining) and its insertion in the mRNA between exon 5, deleted of 72 bp, and exon 6. All deletions caused the formation of a downstream stop-codon. In the tumors, only the TP53 mutated allele was found, con®rming the LOH data.
The three deletions induced the formation of a truncated protein, in the DNA binding domain in cases 2 and 3, and in the oligomerization domain in case 7. Mutant cells with such truncations are known to be defective for normal p53 function. For the four other cases, missense mutations were observed in the DNA binding domain. They can induce a loss of function by disrupting the binding of the protein to DNA, but can also create a gain of function form of the protein (reviewed in Sigal and Rotter, 2000) . The mutation Cys?Phe at codon 135 (case 4) produces a dominant ± negative mutant (Brachmann et al., 1996) . However, in this case, the mutated protein is expressed in absence of the wild type form, a situation which may modify its biological function. The three other mutations have not yet been studied and the activity of the mutated proteins is currently unknown. Nevertheless, the four missense mutations take place at codons coding amino acids evolutionarily conserved in monkey, mouse, rat, chicken, xenopus and trout (Soussi et al., 1990) , a strong indication of their importance for the function of the protein. Changes in these amino acids would be expected to profoundly alter protein function.
Genome instability
Genome instability was analysed using microsatellites, minisatellites and when possible by cytogenetics.
In addition to the 37 loci used for the LOH study of chromosomes 13 and 17 (see Materials and methods and Figure 1 ), eight loci (BAT25, BAT26, BAT40, D2S123, D5S346, D10S137, D17S250, D18S60) considered as highly indicative of the presence of a microsatellite instability (Boland et al., 1998) were analysed. In the absence of LOH, none of these loci displayed dierences in the banding pattern when comparing tumor and normal tissues. Three dierent minisatellite loci were analysed (D1S80, D17S30, H-RAS1). In all cases, the pattern of ampli®cation was similar in normal and tumor tissues (data not shown).
Analysable metaphases were obtained for xenografted tumors from cases 3 and 6. They were studied by classical cytogenetics and FISH using chromosome speci®c painting probes. For case 3, most metaphases were hypotriploid (mean 58 chromosomes, range: 49 ± 61). After R-banding, no more than 25% of chromosomes had a normal appearance. No normal chromosome 13 or 17 was observed. Chromosome painting indicated that sequences from chromosome 13 were located on two derivatives (Figure 2a) . Although dierent, they had one arm in common, suggesting they originated from a unique rearrangement, and thus were likely to have the same parental origin. Sequences from chromosome 17 were distributed on 5 ± 6 chromosomes. Case 6 was hypotetraploid (mean 78, range 76 ± 80 chromosomes). After R-banding, only 10 chromosomes or less had a normal appearance. Surprisingly there were three possible normal chromosome 13, but no normal chromosome 17. Four chromosomes were completely labeled by the chromosome 13 speci®c painting (Figure 2b ). The three normal chromosomes observed after R-banding were not distinguishable from a fourth, rearranged chromosome. This rearranged chromosome likely contained the small distal part of the chromosome 13, which did not undergo LOH (Figure 1) . Sequences from chromosome 17 were present on 8 ± 12 derivatives of various morphologies (Figure 2c ). Painting of other chromosomes also displayed a high level of chromosome rearrangements (not shown). Both the number and morphology of the rearranged chromosomes were highly variable from cell to cell: some of them were only found in one or a few cells, whereas others were found in each analysed metaphase. At later passages in athymic mice, the cells of the two tumors underwent endoreduplications (not shown). Although, these results con®rm the very strong chromosome instability in these two tumors.
Discussion
In this series of patients treated by radiotherapy for a bilateral retinoblastoma, ®ve developed an osteosarcoma, one a leiomyosarcoma and one a schwannoma in the radiation ®eld. As expected from clinical and/or familial data, all patients had a germinal mutation of the RB1 gene, which we could detect in normal somatic cells (Table 2) . It is well established that such mutations not only predispose to retinoblastoma but also to other tumors, in particular to secondary radiation-induced tumors (Wong et al., 1997).
We looked for possible alterations of the normal RB1 allele in tumor cells. In all the cases, a LOH was found. It involved not only the RB1 chromosome region but the whole chromosome 13 (six cases) or a large part of it (one case). In all cases, the remaining allele was that carrying the germ line mutation. Thus, although our series is limited, we conclude that the mechanism underlying the induction of second cancers by radiation in patients heterozygous for a RB1 mutation is unlikely to involve the direct induction of mutations of the normal RB1 allele. The loss of a whole chromosome might be a consequence of chromosome malsegregation, however, this has been extensively looked for and radiation does not seem to directly induce this (United Nations, 1993) . Rather, the data suggest the presence of a chromosome instability in tumor cells.
It has been established in experimental systems that one biological consequence of exposure to ionizing radiation is the induction of delayed genomic instability characterized by gene mutations and chromosome aberrations (reviewed in Little, 2000; Wright, 2000) . These delayed responses have been most eectively demonstrated as non-clonal mutations/aberrations in clonal descendants of irradiated cells. Radiation of both high and low linear energy transfer (LET) is able to induce genome instability but high-LET (a particles, neutrons) seem to induce chromosome instability more eciently than low-LET radiation (X-ray, g). The mechanisms at the origin of the genome instability are currently unknown. The implication of this delayed instability in the development of cancer is presently not established, but in mice a relationship has been found between susceptibility to the induction of chromosome instability in mammary epithelial cells and predisposition to radiation-induced mammary cancer (Ponnaiya et al., 1997) . Some characteristics of the radiationinduced tumors have been analysed to establish if speci®cities could be found as compared with spontaneous tumors.
The panel of TP53 mutations is uncommon TP53 status has been described in several series of radiation-induced sarcomas and carcinomas (Behrens et al., 2000; Brachman et al., 1991; Brat et al., 1999; De Benedetti et al., 1996; Fogelfeld et al., 1996; Gamble et al., 1999; Nakanishi et al., 1998; Nikiforov et al., 1996; Tada et al., 1997) . In these series, the rates of mutations ranged from 0 to 100%, which makes any ®rm conclusion impossible. It must be stressed that some studies were limited to exons known to be recurrently mutated in cancers and that rarer mutations may have escaped.
The pattern of alterations of TP53 observed in our series of tumors is unusual in three respects. Firstly, we found three deletions among seven patients. This 43% rate is too high, compared with that of large series of registered cases: deletions occurred in 9% of 11 100 cases, among which 4.2% involved a single base pair (Soussi et al., 2000) . Thus, the excess of deletions is highly signi®cant in our sample (w 2 =9.9, s=1, P=0.0016). The rates of two and four base pair deletions were of 0.75% and 0.2% respectively in the sample of 11 100 cases, that of deletions larger than 50 base pairs was of 0.1%. When the analysis is restricted to osteosarcomas and leiomyosarcomas, (data were not available for schwannomas), deletions are found in 16 of 120 published mutations (13%), among which 4% involve 1 bp and 0.8%, 4 bp. No deletion of 2 bp or longer than 24 bp was observed. Again, the excess of deletions is highly signi®cant in our series (w 2 =4.5, s=1, P=0.03). Thus, it was highly improbable that these three deletions were observed by chance in our small series.
A second particularity concerns the type of base substitution in the missense mutations. In nonradiation induced tumors, CpG dinucleotides are found mutated at a high rate (Pfeifer, 2000) . It has been suggested that this type of alteration may be related to exposure to chemical mutagens or methylcytosine demethylation. None of our mutations involved a CpG dinucleotide. Bases in DNA can be oxidized by hydroxyl radicals formed by water radiolysis (Wallace, 1998) . 8-oxoguanine (8-oxo-G) is one of the most damaging lesions among oxidized bases (Cadet et al., 1997; Le Page et al., 1999) . The predominant resulting mutation was G : C?T : A (Le Page et al., 1995; Moriya, 1993) , as a consequence of 8-oxo-G: Adenosine pairing (Kouchakdjian et al., 1991) . Such a mechanism could be at play in case 4, but for the other mutations involving a Guanine (cases 1 and 6), it is unlikely that they were formed by oxidation consecutive on irradiation.
A third peculiarity concerns the sites of mutations. For the missense mutations of cases 1, 4 and 5, the transversions observed were rarely found at the same position within the aected codons (Soussi et al., 2000) : 3/114 for codon 237, 2/154 for codon 216 and 11/92 for codon 135. The last missense mutation G?A (case 6) was more frequently observed: 29/63 for codon 258. In addition, these mutations are targeted on evolutionarily-conserved amino-acids (Soussi et al., 1990) . This speci®city, as well as their localization in the DNA binding domain of the protein, probably indicate the eciency of the mutations in altering p53 function. For the deletions, the deleted codons were also rarely found to be involved in the whole data base, with one case for codon 83, 37 cases for codon 164 and 12 cases for codon 284 (Soussi et al., 2000) . In experimental systems, it has been suggested that the delayed gene mutations could represent an increase in spontaneous damages or a diminished ability to correct them (Little et al., 1997) . In our series of radiation-induced tumors, the uncommon panel of mutations found in TP53 suggests the preferential involvement of mechanisms of mutation induced by or associated with ionizing radiation.
Microsatellites and minisatellites are stable
No microsatellite instability was observed in our series of tumors. Published data on microsatellite instability in radiation-induced tumors are con¯icting. A high rate of microsatellite instability was described in a series of nine tumors secondary to irradiation of pediatric tumors (Gafanovich et al., 1999) and in two series of lung and breast cancers (19 each) after therapy of Hodgkin's disease (radiotherapy plus chemotherapy) (Behrens et al., 2000) . In contrast, data from postChernobyl pediatric thyroid carcinomas, suggest that microsatellite instability is not a frequent alteration (Richter et al., 1999) . A similar conclusion was drawn for radiation-induced acute myeloid leukemia in the mouse (Richter et al., 1999) . Cytogenetic data were missing in these studies and it is not possible to establish if in these tumors, the microsatellite instability is associated with a low rate of rearranged chromosomes. Currently, the origin of these discrepancies, which could be related to the histological origin of the cancers and/or with the genetic context, is unknown. The stability of microsatellites found in our series of tumors argues against a direct implication in the development of the loss of function of genes involved in the DNA mismatch repair (Jiricny and NystromLahti, 2000; Peltomaki and de la Chapelle, 1997) . The three tested minisatellites were found to be stable in the seven analysed tumors. Somatic minisatellite mutations have been detected in several models of radiationinduced tumors (Fennelly et al., 1997 and references herein) and in post-Chernobyl tumors (Richter et al., 1999) . In these cases, it was concluded that mutations were not caused directly by radiation-induced DNA damage and that ionizing radiation had a more general indirect eect. The mechanisms at the origin of minisatellite instability, which are presently poorly understood (Jereys et al., 1997) , seem infrequently implicated in the development of the tumors of our series.
Tumors are characterized by a high chromosome instability Cytogenetic studies were possible for two xenografted tumors at early passage. It has been shown that, in these conditions, xenografts gave a relevant picture of the cellular content of the original tumor (Lefrancois et al., 1989) . In the two cases studied by cytogenetics, very complex rearranged and unstable karyotypes were observed. Both for RB1 and TP53, the loss of one gene copy was linked to a large deletion or a chromosome loss. The mechanisms inducing a delayed chromosome instability are not known. However in senescent ®broblasts, it was shown that chromosome losses were non-random and chromosome 13 was among those recurrently involved (Martins et al., 1993) . Thus, in radiation-induced tumors, chromosome instability could be a long term consequence of exposure to radiation. This would ®t with the relatively long delay (14.5 years on average) that was observed between radiotherapy and the second tumor onset of our patients. Whatever the mechanism of promotion of the delayed chromosome instability may be, in the tumors developed after radiotherapy of retinoblastoma, RB1 and TP53 are likely to be implicated in the observed genome instability. In all cases, both RB1 and TP53 were biallelically altered. The absence of normal p53 may be at the origin of a genomic instability associated with the loss of control check points and other functions of the protein. In addition, the tumor suppressor role of RB1 is abolished in the tumors: RB1 regulates the expression of many genes whose products are required for DNA synthesis and cell cycle progression. Transcription activation of at least some of these genes, such as cyclin E, is associated with the loss of proliferation control as a consequence of RB1 inactivation (Almasan et al., 1995; Herrera et al., 1996; Hurford et al., 1997) . However, such a loss of RB1 function, in addition to unchecked proliferation, can also lead to p53-dependent apoptosis (Macleod et al., 1996; Morgenbesser et al., 1994) . Accordingly, loss of RB1 functions may create a survival pressure for the cell to acquire mutations in the p53 pathway. Thus, TP53 mutation eects reinforced by the loss of the tumor suppressor function of RB1 can explain, at least in part, the chromosome instability in these radiationinduced tumors. These two genes are unlikely to be the only ones implicated in the development of the radiation-induced tumors. Alterations, directly or indirectly induced by radiation of other genes which could promote genome instability are expected. The multiple chromosome imbalances observed also suggest the involvement of other genes and other sites of recurrent deletions must be investigated.
Predisposition to radiation-induced tumor
The simple hypothesis proposing that patients heterozygous for a RB1 mutation are at risk of developing a radiation induced cancer by a direct alteration of the remaining allele by the ionizing radiation is obviously wrong, at least for those who developed their second cancer after a long delay. Our data are in favor of a genome instability characterized by a particular panel of mutations associated with a high chromosome instability. The discrimination between the mechanisms linked to predisposition and those linked to irradiation will need further investigation.
Material and methods
Biological material
Tumors were collected at the Institut Curie. Informed consent from patients or parents was obtained for all cases. Three tumors were grown as xenografts in athymic mouse (cases 3, 4 and 6), while both fresh and xenografted tumors were available for case 3. Xenografted tumors were analysed at passage 3. Animal care and housing were in accordance with institutional guidelines as put forth by the MinisteÁ re de l'Agriculture, Direction de la SanteÂ et de la Protection Animale.
DNA and RNA preparation DNA and RNA were extracted from frozen samples using Qiagen kits. Preparation integrity was checked by gel electrophoresis. Reverse transcription was performed using Superscript II (Life Technology) and random primers.
Loss of heterozygosity
LOH was analysed by PCR ampli®cation of microsatellite DNA. Ten ng of template DNA was ampli®ed with 20 pmole of each primer in the presence of [ 32 P]dCTP (Remvikos et al., 1995) . PCR products were separated through 6% acrylamide gel. LOH was visually scored on autoradiograms, the absence of signal of one allele in a tumor was recorded as LOH.
Denaturing gradient gel electrophoresis (DGGE)
RB1 mutations were screened by DGGE analysis of RT ± PCR ampli®ed materials as described (Chevillard et al., 1997 (Chevillard et al., , 1998 . Samples with altered DGGE pro®le were then sequenced. Study of the RB1 cDNA melting domain pro®le indicated that 14 independent RT ± PCR were mandatory to analyse nucleotides 271 to 2962. Sequences of the primer used for RT ± PCR and experimental conditions are available on request.
Sequencing
Overlapping fragments, prepared by RT ± PCR, covering the full length of TP53 and several regions of RB1 cDNAs, were directly sequenced using the dideoxynucleotide method. Exons and parts of introns were sequenced by the same technique using genomic DNA and PCR ampli®cation. Primer sequences and experimental conditions are available on request. Comparisons between pattern of mutations were performed using Yates w 2 .
Instability of microsatellites and minisatellites
In addition to the loci analysed for LOH of chromosomes 13 and 17, eight microsatellites known to be highly informative were used: BAT25, BAT26, BAT40, D2S123, D5S346, D10S137, D17S250, D18S60 (Boland et al., 1998) . The stability of three minisatellites were studied: D1S80 (Sajantila et al., 1992) , D17S30 (Horn et al., 1989) ; H-RAS1 (Calvo et al., 1998) according to the conditions described by these authors.
Cytogenetic analysis
Metaphase spreading, R-banding and¯uorescence in situ hybridization (FISH) using chromosome speci®c painting probes were performed as described (Bernardino et al., 1997; Dutrillaux and Couturier, 1981) .
